Biomarker-Targeted O6-Guanine Alkylation Potentiates ATR Inhibitor Response in De Novo and…

mRNA-dendritic cell antigen vaccine potentiates CD38 CAR-T Cell therapy for relapsed/refractory acute myeloid leukemia.
Yu Lu, Xin Cai, Yanhui Li +11
Theranostics24 Aug 2026Peer-reviewedCC BYFull textOncologyEurope PMC
270 AgenT-797, an allogeneic iNKT cell therapy, enables tumor-cell killing in a human organoid model of immune checkpoint inhibitor–refractory colorectal cancer liver metastases
Nils-Petter Rudqvist, Bishnu Joshi, Dhan Chand +8
Journal for ImmunoTherapy of Cancer6 Nov 2026Peer-reviewedCC BYFull textOncologyDOAJ
611 Imneskibart + low-dose subcutaneous IL-2 ± nivolumab in doublet checkpoint inhibitor-refractory melanoma: promising activity in an ongoing phase 1/2 study
Andrew Haydon, Jose Lutzky, Siwen Hu-Lieskovan +17
Journal for ImmunoTherapy of Cancer7 Nov 2026Peer-reviewedCC BYFull textOncologyDOAJ
CK2 targeting potentiates antineoplastic effects of dual HER2/EGFR inhibitor lapatinib and attenuates growth factor-induced epithelial-mesenchymal transition.
DeZha Robinson, Hogyoung Kim, Alexandra Selico-Dunn +8
Breast cancer research : BCR2 Aug 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
A First-in-Class LZK Inhibitor Suppresses Tumor Growth and Potentiates EGFR and PI3K Pathway Blockade in Head and Neck and Esophageal Cancers
Meghri Katerji, Kailey N. Jackett, Maxine R. Rubin +20
bioRxiv19 Oct 2026PreprintCC BYFull textOncologybioRxivEurope PMCPMC

Cite

BibTeX

@misc{bhardwaj2026biomarkertargeted,
  title = {{Biomarker-Targeted O6-Guanine Alkylation Potentiates ATR Inhibitor Response in De Novo and Relapsed/Refractory AML}},
  author = {P. Bhardwaj and A. Baassiri and R. K. Sundaram and S. Friedman and J. Elia and J. VanOudenhove and C. Heer and A. Kiwan and M. Matthews and S. Gueble and S. Halene and R. Bindra},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.19.751270},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.19.751270v1},
}

RIS

TY  - UNPB
TI  - Biomarker-Targeted O6-Guanine Alkylation Potentiates ATR Inhibitor Response in De Novo and Relapsed/Refractory AML
AU  - P. Bhardwaj
AU  - A. Baassiri
AU  - R. K. Sundaram
AU  - S. Friedman
AU  - J. Elia
AU  - J. VanOudenhove
AU  - C. Heer
AU  - A. Kiwan
AU  - M. Matthews
AU  - S. Gueble
AU  - S. Halene
AU  - R. Bindra
PY  - 2026
DA  - 2026/09/19
PB  - bioRxiv
DO  - 10.64898/2026.09.19.751270
UR  - https://www.biorxiv.org/content/10.64898/2026.09.19.751270v1
ER  -

Related

Cite